Literature DB >> 15581273

Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice.

Roger Burnett1, Guillaume Ravel, Jacques Descotes.   

Abstract

This study was conducted to review the progression with age of renal and other changes in (NZB x NZW) F1 females obtained from a commercial colony, housed under SPF conditions. Sixty-two mice were given food and water ad libitum and sacrificed at intervals up to 47 weeks of age. Routine haematology and urinalysis were performed at regular intervals. The serum levels of IgA, IgG, IgM and antinuclear antibody levels were monitored along with urinary protein. Major organs and tissues from all animals were preserved and examined. Special attention was paid to the kidneys: in addition to routine 4-microm paraffin sections, 1-microm resin sections were prepared and examined. Positive levels of urinary protein (> 1 g/L) were only found in 50% of the animals, even at 32 weeks of age. Histopathologically, the expected type of glomerular damage was present; but the incidence and severity of the change were low, with only 33% of the mice affected at 32 weeks of age. Most mice had fatty vacuolation in the liver. At 24 weeks of age, 50% of the mice sacrificed had haemorrhagic degeneration of the liver. This was not seen at later time points. Only two mice survived until 47 weeks of age. In summary, these findings were of the expected type, but at a much lower incidence and severity than formerly reported. The background of the strain and the experimental conditions are of great importance in the progress of these renal lesions. The lack of homogeneity of the renal changes would make it difficult to determine any influence of xenobiotics on the progress of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581273     DOI: 10.1016/j.etp.2004.04.010

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  15 in total

1.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

2.  MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro.

Authors:  Cristen B Chafin; Nicole L Regna; Rujuan Dai; David L Caudell; Christopher M Reilly
Journal:  Autoimmunity       Date:  2013-09       Impact factor: 2.815

3.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

4.  Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Authors:  Nicole L Regna; Cristen B Chafin; Sarah E Hammond; Abdul G Puthiyaveetil; David L Caudell; Christopher M Reilly
Journal:  Clin Immunol       Date:  2014-01-15       Impact factor: 3.969

5.  Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.

Authors:  Victoria L Wolf; Taylor L Phillips; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 6.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

7.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

8.  Systemic Lupus Erythematosus Associated Pitfalls on 18F-FDG PET/CT: Reactive Follicular Hyperplasia, Kikuchi-Fujimoto Disease, Inflammation and Lymphoid Hyperplasia of the Spleen Mimicking Lymphoma.

Authors:  William Makis; Anthony Ciarallo; Milene Gonzalez-Verdecia; Stephan Probst
Journal:  Nucl Med Mol Imaging       Date:  2017-01-29

9.  IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model.

Authors:  Daniel Zagury; Hélène Le Buanec; Alexis Mathian; Patrick Larcier; Roger Burnett; Zahir Amoura; Dominique Emilie; Gabriel Peltre; Armand Bensussan; Bernard Bizzini; Robert C Gallo; Sophie Koutouzov
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

10.  Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.